Healthcare Services

An Important Factor Driving the Hepatitis Diagnostic Tests Market Is the Increased Blood Transfusions And Donations Fuel Growth In Hepatitis Diagnostic Test Market

April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Estimated Market Size Of The Hepatitis Diagnostic Tests Market During 2026–2030?

The hepatitis diagnostic tests market size has demonstrated robust growth in recent years. It is anticipated to expand from $4.93 billion in 2025 to $5.21 billion in 2026, progressing at a compound annual growth rate (CAGR) of 5.7%. The growth observed in the historic period can be ascribed to factors such as the broadening of hepatitis screening programs, increased laboratory testing volumes, rising awareness concerning viral hepatitis, improved access to diagnostic infrastructure, and the availability of standardized testing protocols.

The market for hepatitis diagnostic tests is projected to experience substantial expansion in the coming years. By 2030, this market is predicted to reach $6.72 billion, expanding at a compound annual growth rate (CAGR) of 6.6%. Factors contributing to this anticipated growth include an escalating demand for decentralized diagnostic methods, increased funding for advanced molecular testing, the spread of home-based testing options, a heightened emphasis on detecting diseases early, and greater uptake in areas with limited resources. Key trends shaping the market during this period involve the wider acceptance of rapid diagnostic tests, a surge in the application of molecular diagnostic technologies, the expanding incorporation of automated laboratory systems, the proliferation of point-of-care testing solutions, and a stronger commitment to timely and precise diagnoses.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13153&type=smp

What Underlying Factors Are Accelerating The Growth Of The Hepatitis Diagnostic Tests Market?

An increase in blood transfusions and donations is anticipated to drive the expansion of the hepatitis diagnostic test market in the future. These two processes, blood transfusions and blood donation, are linked, involving individuals voluntarily giving blood that is then gathered, screened, and later given to patients needing extra blood components for medical treatments or to compensate for blood loss from operations, mishaps, or diseases. To ensure patient safety, hepatitis diagnostic tests are employed for comprehensive blood screening prior to either donation or transfusion. As an illustration, data from August 2023 by the Royal College of Pathologists, an organization based in the UK, indicated that blood transfusion represents the most common procedure for patients admitted to hospitals, with almost 2 million blood components distributed and transfused each year in England, incurring costs exceeding £300 ($390.69) million. Consequently, the growing volume of blood transfusions and donations is a key factor boosting the hepatitis diagnostic test market.

How Are The Various Segments Of The Hepatitis Diagnostic Tests Market Categorized?

The hepatitis diagnostic tests market covered in this report is segmented –

1) By Test Type: Blood Tests, Imaging Tests, Liver Biopsy

2) By Technology: Enzyme-Linked Immunosorbent Assay (ELISA), Rapid Diagnostic Tests (RDTs), Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Test (INAAT), Other Technologies

3) By End User: Hospitals, Diagnostic Laboratories, Blood Bank, Other End Users

Subsegments:

1) By Blood Tests: Serological Tests, Polymerase Chain Reaction (PCR) Tests, Enzyme-Linked Immunosorbent Assays (ELISA)

2) By Imaging Tests: Ultrasound, Computed Tomography (CT), Magnetic Resonance Imaging (MRI)

3) By Liver Biopsy: Percutaneous Biopsy, Transjugular Biopsy, Laparoscopic Biopsy

Which Market Trends Are Creating New Opportunities In The Hepatitis Diagnostic Tests Market?

Major companies operating in the hepatitis diagnostic test market are focusing on developing innovative automated immunoassays, such as Elecsys HCV Duo, to provide reliable customer service. These automated immunoassays, including Elecsys HCV Duo, are laboratory techniques that utilize automation systems and specialized instruments to perform all stages of the immunoassay procedure, encompassing sample handling, reagent mixing, incubation, detection, and result calculation. For instance, in July 2023, Roche Diagnostics India, an India-based biotechnology research company, introduced Elecsys HCV Duo. It represents India’s first commercially available fully automated immunoassay, enabling the simultaneous and independent assessment of hepatitis C virus (HCV) antigen and antibody levels from a single human plasma or serum sample. This also facilitates single specimen testing and streamlines the diagnostic algorithm, thereby reducing the number of visits required for further tests and potentially lessening the testing burden on the healthcare system.

Which Major Firms Influence Developments In The Hepatitis Diagnostic Tests Market?

Major companies operating in the hepatitis diagnostic tests market are Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Roche Diagnostics, Quest Diagnostics Incorporated, Grifols S.A, Hologic Inc., BioMérieux SA, Beckman Coulter Inc., Bio-Rad Laboratories Inc., SD Biosensor Co. Ltd., QIAGEN N.V., DiaSorin S.p.A., Randox Laboratories Ltd., Luminex Corporation, Fujirebio Diagnostics Inc., Trivitron Healthcare Private Limited, Trinity Biotech plc, MP Biomedicals LLC, R-Biopharm AG, Creative Diagnostics, InBios International Inc., Dia.Pro Diagnostic Bioprobes srl, DIALAB GmbH

Read the full hepatitis diagnostic tests market report here:

https://www.thebusinessresearchcompany.com/report/hepatitis-diagnostic-tests-global-market-report

Which Region Is Projected To Dominate The Hepatitis Diagnostic Tests Market During The Forecast Period?

North America was the largest region in the hepatitis diagnostic tests market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hepatitis diagnostic tests market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Hepatitis Diagnostic Tests Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13153&type=smp

Browse Through More Reports Similar to the Global Hepatitis Diagnostic Tests Market 2026, By The Business Research Company

Liver Cancer Diagnostics Global Market Report

https://www.thebusinessresearchcompany.com/report/liver-cancer-diagnostics-global-market-report

Infectious Disease Diagnostics Testing Global Market Report

https://www.thebusinessresearchcompany.com/report/infectious-disease-diagnostics-testing-global-market-report

Viral Hepatitis Global Market Report

https://www.thebusinessresearchcompany.com/report/viral-hepatitis-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795